Last Posted: May 08, 2020
- Efficacy of Immunotherapy in Microsatellite-Stable or Mismatch Repair Proficient Colorectal Cancer—Fact or Fiction?
RB Corcoran et al, JAMA Oncology, May 7, 2020 - Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.
Yu Hui et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 14(1) 25-36 - Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
Shi Yuankai et al. EBioMedicine 2020 Apr 54102731 - Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
Y Yu et al, JAMA Network Open, April 7, 2020 - Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Goldberg Sarah B et al. The Lancet. Oncology 2020 Apr - Moving towards personalized treatments of immune-related adverse events
K Esfahani et al, Nat Rev Clin Oncology, April 3, 2020 - Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.
Urbina-Jara Laura Keren et al. Genes 2019 10(10) - Comparison of commonly used solid tumor targeted gene sequencing panels for estimating tumor mutation burden shows analytical and prognostic concordance within the cancer genome atlas cohort.
Bevins Nicholas et al. Journal for immunotherapy of cancer 2020 Mar 8(1) - Rational Discovery of Response Biomarkers: Candidate Prognostic Factors and Biomarkers for Checkpoint Inhibitor-Based Immunotherapy.
Hou Qianqian et al. Advances in experimental medicine and biology 2020 1248143-166 - A TP53 -associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma.
Xu Feng et al. Oncoimmunology 2020 9(1) 1731943
.png)
No hay comentarios:
Publicar un comentario